Elicera Therapeutics announces participation in several industry and investor meetings in October and November
Gothenburg, October 5, 2021 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company that develops immunooncological treatments focusing on CAR T-cells and oncolytic viruses, announced today that the company will attend the following industry and investor meetings in October and November 2021:
ESGCT (European Society of Gene & Cell Therapy) Virtual Congress 2021 - 19-21 oktober 2021
Associate Professor Di Yu, Development Manager at Elicera Therapeutics, will present preclinical data for the company's iTANK platform.
13th Annual PEGS Europe Summit (Protein & Antibody Engineering Summit) - 2-4 november 2021
Professor Magnus Essand, Chief Scientific Officer at Elicera Therapeutics, will present preclinical data for the company's iTANK platform.
Investival showcase 2021 - 8-15 november
Jamal El-Mosleh, CEO of Elicera Therapeutics, will attend individual meetings with potential partners and investors.
Stora Aktiedagen Göteborg - 9 november
Jamal El-Mosleh, CEO of Elicera Therapeutics, will give a company presentation.
Aktieportföljen Live - 24 november
Jamal El-Mosleh, CEO of Elicera Therapeutics, will give a company presentation.
Stora Aktiedagen Stockholm - 29 november
Jamal El-Mosleh, CEO of Elicera Therapeutics, will give a company presentation.